These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts. Pujuguet P; Hammann A; Moutet M; Samuel JL; Martin F; Martin M Am J Pathol; 1996 Feb; 148(2):579-92. PubMed ID: 8579120 [TBL] [Abstract][Full Text] [Related]
23. NMR structure of the human oncofoetal fibronectin ED-B domain, a specific marker for angiogenesis. Fattorusso R; Pellecchia M; Viti F; Neri P; Neri D; Wüthrich K Structure; 1999 Apr; 7(4):381-90. PubMed ID: 10196121 [TBL] [Abstract][Full Text] [Related]
24. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Matsuura H; Hakomori S Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6517-21. PubMed ID: 2995969 [TBL] [Abstract][Full Text] [Related]
25. Source of oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells. Midulla M; Verma R; Pignatelli M; Ritter MA; Courtenay-Luck NS; George AJ Cancer Res; 2000 Jan; 60(1):164-9. PubMed ID: 10646869 [TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical study of fibronectin in human glioma and meningioma. Kochi N; Tani E; Morimura T; Itagaki T Acta Neuropathol; 1983; 59(2):119-26. PubMed ID: 6188316 [TBL] [Abstract][Full Text] [Related]
27. Endothelins: regulators of extracellular matrix protein production in diabetes. Khan ZA; Farhangkhoee H; Mahon JL; Bere L; Gonder JR; Chan BM; Uniyal S; Chakrabarti S Exp Biol Med (Maywood); 2006 Jun; 231(6):1022-9. PubMed ID: 16741042 [TBL] [Abstract][Full Text] [Related]
28. Expression of tenascin and of the ED-B containing oncofetal fibronectin isoform in human cancer. Nicolò G; Salvi S; Oliveri G; Borsi L; Castellani P; Zardi L Cell Differ Dev; 1990 Dec; 32(3):401-8. PubMed ID: 1711919 [TBL] [Abstract][Full Text] [Related]
30. A pilot pharmacokinetic and immunoscintigraphic study with the technetium-99m-labeled monoclonal antibody BC-1 directed against oncofetal fibronectin in patients with brain tumors. Mariani G; Lasku A; Pau A; Villa G; Motta C; Calcagno G; Taddei GZ; Castellani P; Syrigos K; Dorcaratto A; Epenetos AA; Zardi L; Viale GA Cancer; 1997 Dec; 80(12 Suppl):2484-9. PubMed ID: 9406699 [TBL] [Abstract][Full Text] [Related]
31. Tissue stiffness regulates serine/arginine-rich protein-mediated splicing of the extra domain B-fibronectin isoform in tumors. Bordeleau F; Califano JP; Negrón Abril YL; Mason BN; LaValley DJ; Shin SJ; Weiss RS; Reinhart-King CA Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8314-9. PubMed ID: 26106154 [TBL] [Abstract][Full Text] [Related]
32. Patterns of alternative splicing of fibronectin pre-mRNA in human adult and fetal tissues. Oyama F; Murata Y; Suganuma N; Kimura T; Titani K; Sekiguchi K Biochemistry; 1989 Feb; 28(3):1428-34. PubMed ID: 2713373 [TBL] [Abstract][Full Text] [Related]
33. Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice. Coltrini D; Ronca R; Belleri M; Zardi L; Indraccolo S; Scarlato V; Giavazzi R; Presta M J Pathol; 2009 Dec; 219(4):455-62. PubMed ID: 19824060 [TBL] [Abstract][Full Text] [Related]
34. Expression of the extra domain B of fibronectin, a marker of angiogenesis, in head and neck tumors. Birchler MT; Milisavlijevic D; Pfaltz M; Neri D; Odermatt B; Schmid S; Stoeckli SJ Laryngoscope; 2003 Jul; 113(7):1231-7. PubMed ID: 12838025 [TBL] [Abstract][Full Text] [Related]
35. Interstitial collagenase and the ED-B oncofetal domain of fibronectin are markers of angiogenesis in human skin tumors. Karelina TV; Eisen AZ Cancer Detect Prev; 1998; 22(5):438-44. PubMed ID: 9727625 [TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. Balza E; Borsi L; Allemanni G; Zardi L FEBS Lett; 1988 Feb; 228(1):42-4. PubMed ID: 3422628 [TBL] [Abstract][Full Text] [Related]
37. Differential in vivo and in vitro expression of ED-B+ fibronectin in adult human hematopoiesis. Vogel W; Berndt A; Müller A; Dahse R; Haas KM; Borsi L; Zardi L; Kosmehl H Int J Mol Med; 2003 Dec; 12(6):831-7. PubMed ID: 14612953 [TBL] [Abstract][Full Text] [Related]
38. Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients. Sauer S; Erba PA; Petrini M; Menrad A; Giovannoni L; Grana C; Hirsch B; Zardi L; Paganelli G; Mariani G; Neri D; Dürkop H; Menssen HD Blood; 2009 Mar; 113(10):2265-74. PubMed ID: 19131554 [TBL] [Abstract][Full Text] [Related]
39. Evidence for a differential expression of fibronectin splice forms ED-A and ED-B in Crohn's disease (CD) mucosa. Brenmoehl J; Lang M; Hausmann M; Leeb SN; Falk W; Schölmerich J; Göke M; Rogler G Int J Colorectal Dis; 2007 Jun; 22(6):611-23. PubMed ID: 17136547 [TBL] [Abstract][Full Text] [Related]